SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
莉莉
Lv1
30 积分
2023-08-08 加入
最近求助
最近应助
互助留言
Efficacy and safety of RS plus bevacizumab versus RS plus fruquintinib as the third‐line therapy in patients with refractory metastatic colorectal cancer: A real‐world propensity score matching study
11天前
已完结
Fruquintinib-associated posterior reversible encephalopathy syndrome in a patient with multiply metastatic rectal cancer
11天前
已完结
Remarkable pathological response to neoadjuvant tepotinib in lung adenocarcinoma with MET exon 14 skipping mutation: A case report
18天前
已完结
Synergistic Effects of Fruquintinib Combined with Immune Checkpoint Inhibitors on Metastatic Colorectal Cancer
18天前
已完结
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
1个月前
已完结
Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents
1个月前
已完结
Fruquintinib-Induced Cerebellar Hemorrhage in Left-Sided Descending Metastatic Colorectal Adenocarcinoma: A Case Report and Risk Assessment
1个月前
已完结
Savolitinib conferred sensitivity in a patient with D1228H mutation-induced capmatinib-resistant MET exon 14 skipping mutated lung adenocarcinoma
1个月前
已完结
Drug-induced liver injury associated with savolitinib: a novel case report and causality assessment
2个月前
已完结
Treatment sequences in EGFR mutant advanced NSCLC
2个月前
已完结
没有进行任何应助
已下载【积分已退回】
9个月前
不需下载【积分已退回】
9个月前
已找到【积分已退回】
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论